OBJECTIVES: One previous study has estimated the prevalence of pruritus in SSc, but that study had important limitations due to a relatively small sample size. The present study updates the analyses of the previous study using a substantially larger patient sample. The objectives were to (i) document the proportion of patients who experience pruritus on most days overall and by disease duration and (ii) identify clinical correlates of pruritus. METHODS: Patients from the Canadian Scleroderma Research Group Registry ≥1 year after registry enrolment were asked on two consecutive annual visits whether they had experienced pruritus in the past month on most days and underwent clinical history and medical examination. Multiple logistic regression was used to assess the association between sociodemographic and clinical variables and pruritus. RESULTS: Among 959 patients, 42.6% reported pruritus. Of 693 patients with data for both visits, 333 (48%) did not report pruritus at either visit, 209 (30%) reported pruritus at both visits and 151 (22%) reported pruritus at one, but not the other, visit. The presence of pruritus was independently associated with greater skin involvement [odds ratio (OR) = 1.02, 95% CI 1.00, 1.04, P = 0.017] and greater gastrointestinal involvement (OR = 1.24, 95% CI 1.04, 1.48, P = 0.018). CONCLUSION: Pruritus is common in SSc across the course of the disease and has small but statistically significant associations with the degree of skin involvement and gastrointestinal system involvement.
OBJECTIVES: One previous study has estimated the prevalence of pruritus in SSc, but that study had important limitations due to a relatively small sample size. The present study updates the analyses of the previous study using a substantially larger patient sample. The objectives were to (i) document the proportion of patients who experience pruritus on most days overall and by disease duration and (ii) identify clinical correlates of pruritus. METHODS:Patients from the Canadian Scleroderma Research Group Registry ≥1 year after registry enrolment were asked on two consecutive annual visits whether they had experienced pruritus in the past month on most days and underwent clinical history and medical examination. Multiple logistic regression was used to assess the association between sociodemographic and clinical variables and pruritus. RESULTS: Among 959 patients, 42.6% reported pruritus. Of 693 patients with data for both visits, 333 (48%) did not report pruritus at either visit, 209 (30%) reported pruritus at both visits and 151 (22%) reported pruritus at one, but not the other, visit. The presence of pruritus was independently associated with greater skin involvement [odds ratio (OR) = 1.02, 95% CI 1.00, 1.04, P = 0.017] and greater gastrointestinal involvement (OR = 1.24, 95% CI 1.04, 1.48, P = 0.018). CONCLUSION:Pruritus is common in SSc across the course of the disease and has small but statistically significant associations with the degree of skin involvement and gastrointestinal system involvement.
Authors: Brett D Thombs; Linda Kwakkenbos; Marie-Eve Carrier; Angelica Bourgeault; Lydia Tao; Sami Harb; Maria Gagarine; Danielle Rice; Laura Bustamante; Kelsey Ellis; Delaney Duchek; Yin Wu; Parash Mani Bhandari; Dipika Neupane; Andrea Carboni-Jiménez; Richard S Henry; Ankur Krishnan; Ying Sun; Brooke Levis; Chen He; Kimberly A Turner; Andrea Benedetti; Nicole Culos-Reed; Ghassan El-Baalbaki; Shannon Hebblethwaite; Susan J Bartlett; Laura Dyas; Scott Patten; John Varga Journal: J Psychosom Res Date: 2020-05-14 Impact factor: 3.006
Authors: Marie-Nicole Discepola; Andrea Carboni-Jiménez; Linda Kwakkenbos; Richard S Henry; Jill Boruff; Ankur Krishnan; Carina Boström; S Nicole Culos-Reed; Marie Hudson; David M Leader; Malin Mattsson; Luc Mouthon; Robyn Wojeck; Elizabeth Yakes Jimenez; Maureen Sauve; Joep Welling; Geneviève Guillot; Andrea Benedetti; Brett D Thombs Journal: BMJ Open Date: 2021-05-04 Impact factor: 2.692
Authors: Dominik Samotij; Justyna Szczęch; Carolyn J Kushner; Mohammad Rafiqul Mowla; Aleksandra Dańczak-Pazdrowska; Emiliano Antiga; François Chasset; Fukumi Furukawa; Minoru Hasegawa; Hideo Hashizume; Aminul Islam; Takaharu Ikeda; Aleksandra Lesiak; Adriana Polańska; Laurent Misery; Jacek C Szepietowski; Daisuke Tsuruta; Zygmunt Adamski; Victoria P Werth; Adam Reich Journal: Biomed Res Int Date: 2018-07-25 Impact factor: 3.411
Authors: Attila Gábor Szöllősi; Attila Oláh; Erika Lisztes; Zoltán Griger; Balázs István Tóth Journal: Front Pharmacol Date: 2022-03-07 Impact factor: 5.810